Next Article in Journal
Investigation of the Antitumor Effects of Tamoxifen and Its Ferrocene-Linked Derivatives on Pancreatic and Breast Cancer Cell Lines
Previous Article in Journal
Metformin: A Narrative Review of Its Potential Benefits for Cardiovascular Disease, Cancer and Dementia
Previous Article in Special Issue
Pharmacological Modulation and (Patho)Physiological Roles of TRPM4 Channel—Part 1: Modulation of TRPM4
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Inhibition of the Small-Conductance Ca2+-Activated Potassium Channels Decreases the Sinus Node Pacemaking during Beta-Adrenergic Activation

1
Department of Pharmacology and Pharmacotherapy, Albert Szent-Györgyi Medical School, University of Szeged, 6720 Szeged, Hungary
2
ELKH-SZTE Research Group of Cardiovascular Pharmacology, Hungarian Academy of Sciences, 6725 Szeged, Hungary
3
Department of Pharmacology and Pharmacotherapy, Interdisciplinary Excellence Centre, University of Szeged, 6720 Szeged, Hungary
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2022, 15(3), 313; https://doi.org/10.3390/ph15030313
Submission received: 31 October 2021 / Revised: 24 February 2022 / Accepted: 1 March 2022 / Published: 4 March 2022
(This article belongs to the Special Issue Ion Channels: Current Pharmacological Challenges)

Abstract

:
Sinus pacemaking is based on tight cooperation of intracellular Ca2+ handling and surface membrane ion channels. An important player of this synergistic crosstalk could be the small-conductance Ca2+-activated K+-channel (ISK) that could contribute to the sinoatrial node (SAN) pacemaking driven by the intracellular Ca2+ changes under normal conditions and beta-adrenergic activation, however, the exact role is not fully clarified. SK2 channel expression was verified by immunoblot technique in rabbit SAN cells. Ionic currents and action potentials were measured by patch-clamp technique. The ECG R-R intervals were obtained by Langendorff-perfusion method on a rabbit heart. Apamin, a selective inhibitor of SK channels, was used during the experiments. Patch-clamp experiments revealed an apamin-sensitive current. When 100 nM apamin was applied, we found no change in the action potential nor in the ECG R-R interval. In experiments where isoproterenol was employed, apamin increased the cycle length of the SAN action potentials and enhanced the ECG R-R interval. Apamin did not amplify the cycle length variability or ECG R-R interval variability. Our data indicate that ISK has no role under normal condition, however, it moderately contributes to the SAN automaticity under beta-adrenergic activation.

Graphical Abstract

1. Introduction

The Ca2+-activated K+-current was first described in neurons in 1974 [1]. The existence and functional role of the Ca2+-activated K+-current in the heart was addressed in 1983 and it was concluded that there is no such current in the ventricular myocardium that carries exclusively K+-ions and is activated by intracellular Ca2+ [2]. In 2003, Xu et al. reiterated this issue and described a notable small-conductance Ca2+-activated K+-current (ISK) in ventricular and atrial myocytes of mice and human [3]. Recently, it was found that ISK has an important role in several diseases and conditions such as atrial fibrillation, heart failure [4,5,6], cardiac memory [7,8], and J-wave syndrome [9]. Its important role was shown in normal atrial electrophysiology [10], however, no role was found in ventricular myocytes under normal conditions [11].
Considering that ISK is a Ca2+-driven K+-current, theoretically it could have an important function in sinoatrial node (SAN) automaticity via providing a functional link between the intracellular Ca2+ and the repolarization process, especially under beta-adrenergic condition. However, the function of ISK in SAN cells is poorly elucidated. Recently, Chen et al. and Torrente et al. demonstrated that ISK contributes to the SAN pacemaking in normal rabbit and mouse SAN cells and NCX-knock out cell line [12,13]. In rabbit SAN cells, ISK was even claimed as a key player of the pacemaking mechanism and action potential morphology.
The underlying mechanism of the SAN automaticity, after a long and intense debate, seems to be settled in a concept of the so-called coupled-clock mechanism [14]. It is widely accepted that SAN automaticity is based on the mutual crosstalk of the Ca2+-handling and surface membrane ion channels, where the ensemble of the membrane currents (ICaL, ICaT, IKr, If, INCX) and the rhythmical Ca2+ releases from the sarcoplasmic reticulum (local Ca2+ releases, LCR, Ca2+-clock) form a robust, flexible coupled system, where neither part is dominant, and work synergistically [15]. The ISK, if functionally exists, could be a new component of this coupled-clock system.
Pharmacological control of the heart rate is a crucial intervention of the daily clinical practice in several diseases. However, the applied drugs, such as beta1-adrenoreceptor antagonists, funny current inhibitors (ivabradine), or L-type Ca2+ channels blockers (verapamil, diltiazem) have several limitations [16,17]. Since ISK is a Ca2+-driven current, its contribution to pacemaking could be augmented under beta-adrenergic activation, but this issue was not previously examined. The aim of this study was to investigate the role of ISK and its pharmacological inhibition under normal conditions as well as during beta-adrenergic activation in rabbit SAN cells and on isolated heart.

2. Results

2.1. Immunoblotting and Confocal Microscopy

SK2 expression was directly detected on isolated sinus node cells. Confocal microscopy on immunostained sinus node cells revealed abundant expression of SK2 channels on the surface membrane (Figure 1A). The SK2 fluorescence intensity does not show difference from the sinus node-specific HCN4 (n = 16 cells/4 animals; p = 0.97; Figure 1B). Colocalization of the SK2 immunofluorescence with WGA Texas-Red fluorescence was then analyzed by Pearson’s Correlation Coefficient (PCC) and we found that average PCC values of SK2 (0.82; (0.75–0.86)) were similar with HCN4 (0.82; (0.76–0.89); n = 16 cells/4 animals; p = 0.89; Figure 1C). These data suggest that SK2 is represented in the membrane of sinus node cells as HCN4.

2.2. Measurement of the Apamin-Sensitive Current

In the first set of electrophysiological measurements, we aimed to investigate the potential existence of ISK in SAN cells. In order to address this issue, a selective inhibitor apamin was employed in 100 nM concentration, which fully inhibits all three isoforms of the SK-channels. As SK-channels carry Ca2+-sensitive current, the intracellular Ca2+ level was set to 500 nM to activate the channels by using an appropriate mixture of EGTA and CaCl2. Rectangular voltage steps were applied from −80 mV to 50 mV from a holding potential of −60 mV. Application of apamin revealed a time-independent apamin-sensitive current within the membrane potential range of −40 to 50 mV (Figure 2).
For further validation of the current, in the next set of experiments we buffered the intracellular Ca2+ with 10 mM BAPTA, and the same voltage protocol was applied (Figure 3). In this case, 100 nM apamin failed to dissect any current fragment from the control current, indicating that no ISK was activated without free intracellular Ca2+.
The apamin-sensitive current was also determined under a representative SAN action potential waveform, in the absence and in the presence of 200 nM isoproterenol without using Ca2+-chelators in the patch pipette. Figure 4A demonstrates that 200 nM isoproterenol did not change the diastolic Ca2+ level (104 ± 30 nM → 131 ± 33 nM; n = 8, N = 6; p = 0.13). The systolic peak was 566 ± 99 nM under control condition and was significantly increased to 732 ± 112 nM after isoproterenol application (n = 8, N = 6; p < 0.05). In the absence of isoproterenol, 100 nM apamin failed to significantly alter the peak of the total current (76 ± 8 pA → 59 ± 9 pA; n = 8, N = 5; panel B). In contrast, when 200 nM isoproterenol was applied previously, 100 nM apamin markedly decreased the peak of total current (144 ± 33 pA → 78 ± 15 pA; p < 0.05; n = 8, N = 6; panel C). Panel D demonstrates the comparison of apamin-sensitive currents in the absence (black curve) and in the presence of 200 nM isoproterenol (18 ± 6 pA vs 65 ± 20 pA; p < 0.05). The average cell capacitance of the current measurements was: 56.7 ± 4 pA/pF (n = 32).
Since the SK-channels are expected to carry a functional current depending on the intracellular Ca2, they may contribute to the SAN action potential and pacemaking in rabbit-isolated SAN cells. This assumption was investigated in the subsequent experiments.

2.3. The ISK Has No Role in the SAN Pacemaking under Normal Condition

The effect of selective SK-channel inhibition was tested in SAN pacemaking under basal condition (i.e., without beta-adrenergic modulation) by applying 100 nM apamin. Action potentials were measured by perforated patch-clamp technique from spontaneously beating SAN cells. It was found that apamin failed to influence any parameter of the SAN action potential (control → apamin; cycle length: 391 ± 30 → 388 ± 33 ms; cycle length variability: 43 ± 10 → 41 ± 13 ms; APD: 176 ± 17 → 193 ± 25 ms; slope of diastolic depolarization: 0.08 ± 0.01 → 0.08 ± 0.01 ms; n = 7, Figure 5).

2.4. ISK Contributes to the SAN Action Potential under Beta-Adrenergic Activation

The failure of apamin to influence SAN pacemaking demonstrated in Figure 5 indicated that the intracellular Ca2+ level may not reach an appropriate level to activate a sufficiently large current during the action potential. In this set of experiments, we activated the beta-receptors by the application of 200 nM isoproterenol to enhance the intracellular Ca2+ content of the cells. Under this condition (Figure 6), the application of 100 nM apamin significantly lengthened the cycle length (323 ± 17 → 387 ± 28 ms, p < 0.05, n = 7), without altering the short-term cycle length variability in a statistically significant manner (26 ± 6 → 40 ± 11 ms, p = 0.21, n = 7), but prolonged the APD (153 ± 10 → 176 ± 8 ms, p < 0.05, n = 7) and did not alter the slope of diastolic depolarization (0.11 ± 0.01 → 0.095 ± 0.01 mV/ms, n = 7). The maximal diastolic potential also did not show change upon apamin application (−56 ± 2 → 60 ± 3 mV, n = 7).

2.5. Inhibition of the ISK Lengthens the ECG R-R Interval under Beta-Adrenergic Activation

The effect of 100 nM apamin was tested on ex-vivo isolated Langendorff-perfused hearts (Figure 7). During measurements, 40 consecutive ECG R-R intervals were measured and the mean R-R intervals and short-term R-R variability were calculated. Under normal conditions (i.e., without beta-adrenergic activation), 100 nM apamin failed to alter both the ECG R-R intervals (373 ± 20 → 393 ± 17 ms, p = 0.43, n = 10) and the R-R variability (6.4 ± 1.2 → 6.8 ± 1.4 ms, n = 10). Parallel with the apamin experiments, a time control group was measured where the vehicle of apamin was applied in order to detect any non-specific or time-dependent changes. No change was found in the ECG R-R interval (379 ± 10 → 373 ± 17 ms, n = 10) nor in the R-R variability (6.9 ± 1.6 → 7.1 ± 1.6 ms, n = 10).
In the second set of Langendorff experiments, we aimed to substantially activate the beta-adrenergic receptors in order to enhance the intracellular Ca2+ without causing arrhythmogenic events. Our preliminary experiments showed that 500 nM isoproterenol shortens the ECG R-R interval by 44 ± 4%, while arrhythmias were not observed. Under this condition, 100 nM apamin lengthened the ECG R-R interval (364 ± 17 → 200 ± 5 → 223 ± 10 ms, p < 0.05, n = 9) but did not alter the R-R variability (6.0 ± 1.7 → 4.4 ± 0.6 → 7.1 ± 3.8 ms, p = 0.41, n = 10). The parallel time control measurements exerted no statistically significant change in these variables upon administration of the vehicle (R-R interval: 370 ± 16 → 223 ± 8 → 231 ± 11 ms, n = 10; R-R variability: 8.1 ± 2.1 → 3.0 ± 0.3 → 4.0 ± 0.5 ms, n = 10).
In order to compare the magnitude and nature of the apamin effect to a well-known bradycardic agent, the effect of 3 µM ivabradine was examined in the presence of 500 nM isoproterenol. As it was expected, the application of ivabradine lengthened the ECG R-R interval (386 ± 48 → 257 ± 34 → 330 ± 41 ms, p < 0.05, n = 7), however, it also significantly increased the ECG R-R variability (11.7 ± 4.0 → 6.0 ± 0.7 → 20.0 ± 5 ms, n = 7).

3. Discussion

In this study we analyzed the possible role of the small-conductance Ca2+-activated K+-current under basal condition and during beta-adrenergic stimulation. Previous studies reported the functional role of SK-channels in SAN pacemaking without adrenergic stimulation. In contrast, in this study we failed to demonstrate a significant effect of SK-inhibition under normal condition, unless beta adrenergic stimulation was applied.
We do not know the discrepancy of the difference between our and the study of Chen at al. [12], but differences in the intracellular Ca2+ level cannot be ruled out between the two studies. Further investigations are necessary to resolve this issue.
The most important findings of this paper are: (i) the SK2-channels are expressed in rabbit SAN sarcolemma. (ii) The ISK has no role in SAN pacemaking with basal intracellular Ca2+ level. (iii) Beta-adrenergic stimulation activates the ISK and its inhibition causes moderate decrease in spontaneous automaticity via APD lengthening without increasing the cycle length variability.

3.1. The SK Channels Are Expressed in Rabbit SAN Myocytes

A previous paper demonstrated the expression of SK-channel in mice myocytes [13], however, based on our best knowledge this is the first data regarding the expression of SK2 in rabbit SAN cells, which is emphasized by the fact that the vast majority of SAN data are obtained from rabbit cells. Since a previous study indicated that the selective SK-channel inhibitor apamin exerts the highest sensitivity toward SK2 [18], the expression of SK2 isoform was elucidated in this study. Our experiments showed that the SK2 isoform is expressed in the surface membrane of rabbit SAN myocytes.

3.2. The Apamin-Sensitive Current Is Present in SAN Cells

SK-channels can be divided into three major subgroups: SK1 channels are encoded by KCNN1, SK2-channel encoded by KCNN2, and SK3 encoded by KCNN3 gene. Apamin, a polypeptide blocker of the ISK isolated from bee venom, selectively blocks the current with isoform-dependent effectivity [19]. SK1 channels have the lowest sensitivity (IC50~10 nM); the SK3 is moderately sensitive (IC50~1 nM); and SK2 exerts the highest sensitivity (IC50~40 pM) [19]. This indicates that the applied 100 nM apamin in this study is far above the IC50-values of any channel subtypes, therefore, complete SK-channel block is expected in our experiments.
The SK-channels are suggested to be voltage-independent ion channels, activated by the rise of intracellular Ca2+ concentration, and carrying repolarizing K-currents [3]. Previous studies suggested that inward rectification of the SK-channels is caused by voltage-dependent block of intracellular divalent ions, however, a later study identified an intrinsic mechanism of channels causing inward rectification, which is independent of divalent ions [20].
Our patch clamp experiments revealed apamin-sensitive current in the voltage range between −40 to +40 mV when the intracellular Ca2+ was buffered to 500 nM. The half-maximal Ca2+ concentration for channel activation was reported as 300 nM [21], therefore, this Ca2+ concentration is suggested to cause nearly maximal current activation. When intracellular Ca2+ was buffered to 500 nM, the apamin-sensitive difference current was monotonously enhanced as the voltage was increased from −60 to + 40 mV. The current-voltage characteristic of the apamin-sensitive current both in terms of absolute current values and voltage-dependence was found to be similar to those that were illustrated in a previous study [13]. This current-voltage characteristic of the ISK may imply that notable current could be expected above −20 mV, which corresponds to the main repolarization, at the same time it is plausible that marginal current is activated during the maximal diastolic potential. It is underpinned by the fact that modelling and experimental results indicate that intracellular Ca2+ level is the highest during early repolarization and considerable decays during the terminal phase of the repolarization [22,23]. Therefore, neither the membrane potential nor the intracellular Ca2+ favour ISK activation at the maximal diastolic potential. In line with this, we did not find change in the maximal diastolic potential and any secondary change in the diastolic depolarization. As a negative control, highly buffered cells were used to demonstrate the Ca2+ sensitivity of the apamin-sensitive current. In contrast to high depolarization (i.e., +40 mV), apamin-sensitive current was not detected in the absence of free intracellular Ca2+.
For further validation, we analyzed the effect of apamin under a representative SAN action potential waveform without Ca2+ chelators in the patch pipette. In contrast to experiments with buffered Ca2+, we found negligible apamin-sensitive current under normal conditions in the presence of dynamic Ca2+ changes. Ca2+ transient measurements indicated that systolic peak of intracellular Ca2+ was barely larger than 500 nM and declined fast, which may induce small ISK. In contrast, when 200 nM isoproterenol was employed, intracellular Ca2+ was increased and apamin-sensitive current was considerably larger.

3.3. ISK Has No Role in Sinus-Node Pacemaking under Normal Conditions but Its Inhibition Lengthens APD during Beta-Adrenergic Activation

Under normal conditions, apamin-induced AP alteration was not observed, which is in contrast to a previous report where ~18% cycle length increase was observed after apamin application under normal conditions in mouse SAN cells [13]. This extent of effect is comparable to the effect of If inhibition by ivabradine under normal conditions [24]. Similarly, apamin also failed to alter the ECG R-R interval in Langendorff-perfused hearts in our study without adrenergic stimulation. A recent clinical study also reported similar results. Forty-seven healthy male volunteers were examined during AP30663 (ISK inhibitor) administration. AP30663 did not influence the R-R interval, regardless of the applied dose [25]. These results are in line with experiments demonstrating marginal apamin-sensitive current during the action potential in response to dynamic Ca2+ changes, under normal conditions.
Activation of the β-adrenoreceptors induces the adenylate-cyclase via stimulatory G-proteins, leading to increased intracellular cyclic AMP (cAMP) level. The elevated cAMP then increases the protein-kinase A level, which phosphorylates the L-type Ca2+ channels. The L-type Ca2+ channel-phosphorylation increases the Ca2+ influx, thus causing a net gain of the intracellular Ca2+. The elevated intracellular Ca2+ also increases the CaM/CaMKII axis, which is involved in several Ca2+-dependent processes [26,27,28]. Experiments demonstrated in Figure 4C,D suggest that the increased intracellular Ca2+ increases the current density of the apamin-sensitive current, where inhibition could influence the sinus-node pacemaking. In order to address this issue, the beta-receptor agonist, isoproterenol, was employed.
Application of apamin in the presence of beta-receptor activation caused a ~20% increase in the cycle length, while the slope of the diastolic depolarization was not changed. This result implies that the increase of cycle length after ISK inhibition was attributable to the increased APD, but the diastolic depolarization was not changed. This effect could be attributable to: (i) the current-voltage diagram and apamin-sensitive current during the canonical action potential suggest marginal or no current in the voltage range of diastolic depolarization and (ii) the intracellular Ca2+ level is considerably decreased during the diastolic depolarization. In agreement with this result, the ECG R-R intervals of Langendorff-perfused hearts were increased by 12% after apamin administration when beta-receptors were activated.

3.4. ISK inhibition Does Not Increase Cycle Length Variability

The rhythmicity of spontaneous action potential and ECG R-R interval was characterized by the short-term cycle length variability (in the case of action potentials) and short-term R-R variability (in the case of ECG measurements). The coupled-clock hypothesis claims that cycle length variability is an important indicator of the coupling between the Ca2+-clock and the surface membrane ion channels: When the synchronization between the two clocks is strong, the variability is low. Any intervention disrupting the Ca2+-clock and/or the membrane clock attenuates the coupling and leads to increased cycle length and cycle length variability [29]. In this study, neither the cellular measurements nor the isolated heart experiments show a significant increase in the cycle length variability after apamin administration. This result suggests that ISK may not be involved in the ionic mechanism that directly governs the pacemaker mechanism. However, it may also imply that inhibition of ISK under beta-adrenergic activation could be considered a safe intervention to decrease the heart rate.
The effect of apamin was compared to the effect of ivabradine, and it was found that the ECG R-R interval-increasing effect of apamin was 1/3 of the ivabradine (~12 vs. ~30%). This result implies that the significance of ISK in controlling the heart rate is markedly smaller than the If; this probably provides extra repolarizing current during beta-adrenergic stimulation, which may increase the flexibility of pacemaking. In contrast, ivabradine also significantly augmented the cycle length variability since If is a principal component of the coupled-clock mechanism.

4. Materials and Methods

4.1. Animals

New Zealand white rabbits from both genders weighing 2.0–2.5 kg were used for experiments obtained from a licensed supplier (Innovo Ltd., Budapest, Hungary).

4.2. Cell Isolation

Isolated single SAN cells were obtained by enzymatic dissociation. Rabbits were sacrificed by concussion after intravenous administration of 400 IU/kg heparin. The heart was rapidly removed and placed into a solution containing in mM: 135 NaCl, 4.7 KCl, 1.2 KH2PO4, 1.2 MgSO4, 10 HEPES, 4.4 NaHCO3, 10 glucose, and 1.8 CaCl2 (titrated to pH 7.2 with NaOH). The heart was mounted on a cc. 60 cm high modified Langendorff column and was perfused with oxygenated solution at 37 °C. In the initial period, the blood was washed out (3–5 min) from the heart, then it was continuously perfused with nominally Ca2+-free solution until the heart ceased contractions (cca. 10 min). The enzymatic dissociation was performed by using 1.8 mg/mL (260 U/mL) collagenase (type II, Worthington) and 33 µM CaCl2 in the perfusate. After 13–14 min, the heart was taken off the cannula. The right atrium of the heart was cut and the SAN region was excised and cut into small pieces. The strips were placed into enzyme free isolation solution containing 1 mM CaCl2 and equilibrated at 37 °C for 15 min. The cells were separated by filtering through a mesh and were stored at room temperature.

4.3. SK2 Immunocytochemistry

Rabbit sinus node cells were isolated from the sinus-node, then were fixed on glass coverslips with acetone. The cell membrane was labelled Wheat Germ Agglutinin Texas Red-X Conjugate (WGA-TxRed) (ThermoFischer, Waltham, MA, USA; 1:500). After membrane labelling, the samples were blocked for 1 h with PBST (PBS with 0.01% Tween) containing 2.5% BSA at room temperature. SK2 and HCN4 were labelled with anti-KCa2.2 (SK2) (Alomone, Jerusalem, Israel; 1:50) and anti-HCN4 (Alomone; 1:50) primary antibody overnight at 4 °C. Next day, the cells were incubated with Goat anti-Guinea Pig IgG Alexa Fluor 488 secondary antibody (ThermoFischer; 1:500) for 1 h at room temperature. Fluorescent images were captured by an LSM 880 (Zeiss, Oberkochen, Germany) laser scanning confocal microscope. Images were quantitatively analyzed by ImageJ software. Control samples were incubated with secondary antibody only (No Primary Control).

4.4. Measurement of Apamin-Sensitive Current

The isolated SAN cells were placed in a low volume chamber (RC47FSLP, Warner Instruments, Hamden, CT, USA). Five minutes were allowed for the cells to settle and adhere, and the solution was continuously superfused by a peristaltic pump (C.P.78012-45, Ismatec, Zurich, Switzerland). Patch-pipettes were created from borosilicate glass capillaries using a P-97 microelectrode puller (Sutter Instruments, Novato, CA, USA), having a tip resistance between 1.5–2.5 MΩ. Ionic currents were recorded by using Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA, USA). Membrane currents were digitalized by Digidata 1550B (Molecular Devices, Sunnyvale, CA, USA) with 250 kHz under software control (pClamp 10.0, Molecular Devices, Sunnyvale, CA, USA). The temperature of the measurements was kept at 37 °C by using TC-344B temperature controller (Warner Instruments, USA).
Apamin-sensitive current was measured by rectangular voltage pulses, or by representative SAN action potential waveform. Rectangular voltage steps before and after 100 nM apamin application were employed from a holding potential of −60 mV. The membrane was depolarized to 50 mV for 500 ms by using 10 mV voltage steps. The internal solution contained (in mM): KCl 40, K2ATP 5, HEPES 10, MgCl2 5, and GTP 0.1 and was titrated to pH 7.2 by using KOH. The free Ca2+ concentration in the pipette solution was set to 500 nM by using an appropriate mixture of EGTA and CaCl2 (calculated by the Maxchelator software). In experiments where the intracellular Ca2+ was highly buffered, we used 10 mM BAPTA without applying CaCl2 in the pipette. The composition of the external solution was (in mM): NaCl 144, NaH2PO4 0.4, KCl 4, MgSO4 0.53, CaCl2 1.8, HEPES 5, glucose 5.5, titrated to pH 7.4 with NaOH.
In another set of experiments, the cells were paced using a canonical AP waveform by the average of 10 independent action potentials from previously recorded perforated patch clamp experiments. The parameters of this representative AP waveform were: cycle length: 410 ms, AP duration: 180 ms, maximal diastolic potential: −57 mV, overshoot: 24 mV, and diastolic depolarization slope: 0.124 mV/ms. Two experimental groups were established. In the first group, the current was recorded first in normal Tyrode’s solution (as previously described) as the control current, then 100 nM apamin was applied. In the other experimental group, the solutions were supplemented with 200 nM isoproterenol to enhance the intracellular Ca2+ of the SAN cells. Apamin-sensitive current was determined as a difference current. The pipette solution was as previously described without chelators.

4.5. Measurement of Ca2+ Transients

Ca2+ transients were measured from spontaneously active isolated SAN cells. Cells were loaded with Fluo-4 AM (5 µM) fluorescent dye. The isolated cells were kept in darkness at room temperature and were loaded with the dye for 20 min. Fluorescence measurements were performed on the stage of an Olympus IX 71 inverted fluorescence microscope. The dye was excited at 480 nm and the emitted fluorescence was detected at 535 nm. Optical signals were sampled at 1 kHz and recorded by a photon counting photomultiplier (Hamamatsu, model H7828; Hamamatsu Photonics Deutschland GmbH, Herrsching am Ammersee, Germany). Optical signal was converted to voltage using photon-voltage converter (Ionoptix, Westwood, MA, USA) and analyzed by pClamp 10.0 (Molecular Devices, Sunnyvale, CA, USA). Spontaneously and rhythmically contracting cells were chosen, therefore, no external pacing was needed to record Ca2+ transients. Amplitudes of the measured Ca2+ transients were calculated as differences between systolic and diastolic values. To obtain maximal fluorescence (Fmax), the cells were damaged by a patch pipette at the end of the experiment. Ca2+ was calibrated using the following formula: Kd(F-Fmin)/(Fmax-F). The Kd of the Fluo-4 AM was set to 335 nM. The extracellular solution was normal Tyrode’s solution as was previously described.

4.6. Action Potential Measurements from Single Cells by Current Clamp Configuration

Action potentials were measured from spontaneously beating sinus-node cells by using the perforated patch-clamp technique as was described in a previous study [30]. Normal Tyrode’s solution was applied, containing (in mM): 144 NaCl, 0.4 NaH2PO4, 4 KCl, 0.53 MgSO4, 1.8 CaCl2, 5.5 glucose, and 5 HEPES, titrated to pH 7.4 with NaOH. The microelectrodes were filled with a solution that contained (in mM): 120 K-gluconate, 2.5 NaCl, 2.5 MgATP, 2.5 Na2ATP, 5 HEPES, 20 KCl, titrated to pH 7.2 with KOH. 35 µM β-escin was employed in the pipette solution to achieve the membrane patch perforation.
The parameters of the APs were calculated as follows:
(a)
Maximum diastolic potential (MDP) was defined as the most negative potential before the next AP depolarization.
(b)
Take off potential (TOP) was calculated as the voltage measured at the time when the voltage derivative exceeded 0.5 mV/ms.
(c)
The slope of diastolic depolarization was defined as the mean voltage derivative of the AP between MDP and take off potential.
(d)
Action potential duration (APD) was obtained as the time interval between TOP and the next MDP.
(e)
Cycle length was calculated between the peaks of two consecutive APs.
(f)
All experiments in this study were carried out at 37 °C.

4.7. Langendorff-Perfusion Measurements on Isolated Hearts

ECG of isolated rabbit hearts were obtained in Langendorff-perfused hearts as described before [31]. Rabbits were sacrificed by concussion after 400 IU heparin were injected intravenously. The excised hearts were mounted by the aorta on a Langendorff-apparatus and retrogradely perfused with modified Krebs-Henseleit bicarbonate buffer (KHB) at a constant pressure (80 Hgmm). The KHB solution contained (in mM): NaHCO3 25; KCl 4.3; NaCl 118.5; MgSO4 1.2; KH2PO4 1.2; glucose 10; CaCl2 1.8, having a pH of 7.4 ± 0.05 when gassed with 95% O2 + 5% CO2.
The electrical activity as electrocardiogram (ECG) was obtained by the three lead custom-made electrodes and signal amplifier (Experimetria Ltd., Budapest, Hungary). Signal processing and analysis was carried out using HaemoSys (Experimetria Ltd., Budapest, Hungary).

4.8. Statistics

Normal distribution of the data was verified by using Shapiro–Wilk test. Statistical significance (p < 0.05) was assessed using Student’s t-test and repeated measures ANOVA depending on the experiment. Data are presented as means ±S.E.M.

5. Conclusions

Our results indicate that ISK has no or very limited role in SAN pacemaking under basal condition, however, it may contribute to the repolarization under beta-adrenergic activation. Selective inhibition of ISK induces a moderate cycle length increase, with the latter effect being attributed to the lengthening of APD. Further in-vitro and in-vivo studies are required to estimate the possible therapeutic potential of ISK inhibition as a supportive heart-rate-reducing agent.

Author Contributions

Conceptualization, N.N. and A.V.; methodology, N.N.; investigation, G.B., N.T., S.D., J.S. and Z.K.; resources, N.N. and A.V.; data curation, G.B., N.T. and N.N.; writing—original draft preparation, N.N.; writing—review and editing, N.T. and A.V.; visualization, N.N.; funding acquisition, N.T., A.V. and N.N. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Research Development and Innovation Office (FK-129117 to N.N.) and the Ministry for Innovation and Technology (ÚNKP-21-3-SZTE-106 to N.T.).

Institutional Review Board Statement

All experiments were conducted in compliance with the Guide for the Care and Use of Laboratory Animals (USA NIH publication No 85-23, revised 1996) and conformed to Directive 2010/63/EU of the European Parliament. The protocols were approved by the Review Board of the Department of Animal Health and Food Control of the Ministry of Agriculture and Rural Development, Hungary (XIII./1211/2012).

Informed Consent Statement

Not applicable.

Data Availability Statement

Data is contained within the article.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Meech, R.W.; Standen, N.B. Calcium-mediated potassium activation in Helix neurones. J. Physiol. 1974, 237, 43–44. [Google Scholar]
  2. Eisner, D.A.; Vaughan-Jones, R.D. Do calcium-activated potassium channels exist in the heart? Cell Calcium 1983, 4, 371–863. [Google Scholar] [CrossRef]
  3. Xu, Y.; Tuteja, D.; Zhang, Z.; Xu, D.; Zhang, Y.; Rodriguez, J.; Nie, L.; Tuxson, H.R.; Young, J.N.; Glatter, K.A.; et al. Molecular identification and functional roles of a Ca(2+)-activated K+ channel in human and mouse hearts. J. Biol. Chem. 2003, 278, 49085–49094. [Google Scholar] [CrossRef] [Green Version]
  4. Chua, S.K.; Chang, P.C.; Maruyama, M.; Turker, I.; Shinohara, T.; Shen, M.J.; Chen, Z.; Shen, C.; Rubart-von der Lohe, M.; Lopshire, J.C.; et al. Small-conductance calcium-activated potassium channel and recurrent ventricular fibrillation in failing rabbit ventricles. Circ. Res. 2011, 108, 971–979. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Kirchhoff, J.E.; Diness, J.G.; Sheykhzade, M.; Grunnet, M.; Jespersen, T. Synergistic antiarrhythmic effect of combining inhibition of Ca2⁺-activated K⁺ (SK) channels and voltage-gated Na⁺ channels in an isolated heart model of atrial fibrillation. Heart Rhythm 2015, 12, 409–418. [Google Scholar] [CrossRef]
  6. Nattel, S. Calcium-activated potassium current: A novel ion channel candidate in atrial fibrillation. J. Physiol. 2009, 587, 1385–1386. [Google Scholar] [CrossRef] [PubMed]
  7. Yin, D.; Chen, M.; Yang, N.; Wu, A.Z.; Xu, D.; Tsai, W.C.; Yuan, Y.; Tian, Z.; Chan, Y.H.; Shen, C.; et al. Role of apamin-sensitive small conductance calcium-activated potassium currents in long-term cardiac memory in rabbits. Heart Rhythm 2018, 15, 761–769. [Google Scholar] [CrossRef] [PubMed]
  8. Chan, Y.H.; Tsai, W.C.; Ko, J.S.; Yin, D.; Chang, P.C.; Rubart, M.; Weiss, J.N.; Everett, T.H.t.; Lin, S.F.; Chen, P.S. Small-Conductance Calcium-Activated Potassium Current Is Activated During Hypokalemia and Masks Short-Term Cardiac Memory Induced by Ventricular Pacing. Circulation 2015, 132, 1377–1386. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Chen, M.; Xu, D.Z.; Wu, A.Z.; Guo, S.; Wan, J.; Yin, D.; Lin, S.F.; Chen, Z.; Rubart-von der Lohe, M.; Everett, T.H.t.; et al. Concomitant SK current activation and sodium current inhibition cause J wave syndrome. JCI Insight 2018, 3, e122329. [Google Scholar] [CrossRef] [PubMed]
  10. Skibsbye, L.; Poulet, C.; Diness, J.G.; Bentzen, B.H.; Yuan, L.; Kappert, U.; Matschke, K.; Wettwer, E.; Ravens, U.; Grunnet, M.; et al. Small-conductance calcium-activated potassium (SK) channels contribute to action potential repolarization in human atria. Cardiovasc. Res. 2014, 103, 156–167. [Google Scholar] [CrossRef] [Green Version]
  11. Nagy, N.; Szuts, V.; Horváth, Z.; Seprényi, G.; Farkas, A.S.; Acsai, K.; Prorok, J.; Bitay, M.; Kun, A.; Pataricza, J.; et al. Does small-conductance calcium-activated potassium channel contribute to cardiac repolarization? J. Mol. Cell. Cardiol. 2009, 47, 656–663. [Google Scholar] [CrossRef]
  12. Chen, W.T.; Chen, Y.C.; Lu, Y.Y.; Kao, Y.H.; Huang, J.H.; Lin, Y.K.; Chen, S.A.; Chen, Y.J. Apamin modulates electrophysiological characteristics of the pulmonary vein and the Sinoatrial Node. Eur. J. Clin. Investig. 2013, 43, 957–963. [Google Scholar] [CrossRef] [PubMed]
  13. Torrente, A.G.; Zhang, R.; Wang, H.; Zaini, A.; Kim, B.; Yue, X.; Philipson, K.D.; Goldhaber, J.I. Contribution of small conductance K+ channels to sinoatrial node pacemaker activity: Insights from atrial-specific Na+/Ca2+ exchange knockout mice. J. Physiol. 2017, 595, 3847–3865. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Kohajda, Z.; Loewe, A.; Toth, N.; Varro, A.; Nagy, N. The Cardiac Pacemaker Story-Fundamental Role of the Na+/Ca2+ Exchanger in Spontaneous Automaticity. Front. Pharmacol. 2020, 11, 516. [Google Scholar] [CrossRef] [PubMed]
  15. Lakatta, E.G.; Maltsev, V.A.; Vinogradova, T.M. A coupled SYSTEM of intracellular Ca2+ clocks and surface membrane voltage clocks controls the timekeeping mechanism of the heart’s pacemaker. Circ. Res. 2010, 106, 659–673. [Google Scholar] [CrossRef] [Green Version]
  16. Komajda, M.; Isnard, R.; Cohen-Solal, A.; Metra, M.; Pieske, B.; Ponikowski, P.; Voors, A.A.; Dominjon, F.; Henon-Goburdhun, C.; Pannaux, M.; et al. Effect of ivabradine in patients with heart failure with preserved ejection fraction: The EDIFY randomized placebo-controlled trial. Eur. J. Heart Fail. 2017, 19, 1495–1503. [Google Scholar] [CrossRef] [Green Version]
  17. DeWitt, C.R.; Waksman, J.C. Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity. Toxicol. Rev. 2004, 23, 223–238. [Google Scholar] [CrossRef] [PubMed]
  18. Adelman, J.P.; Maylie, J.; Sah, P. Small-conductance Ca2+-activated K+ channels: Form and function. Annu. Rev. Physiol. 2012, 74, 245–269. [Google Scholar] [CrossRef] [PubMed]
  19. Lamy, C.; Goodchild, S.J.; Weatherall, K.L.; Jane, D.E.; Liégeois, J.F.; Seutin, V.; Marrion, N.V. Allosteric block of KCa2 channels by apamin. J. Biol. Chem. 2010, 285, 27067–27077. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Li, W.; Aldrich, R.W. Electrostatic influences of charged inner pore residues on the conductance and gating of small conductance Ca2+ activated K+ channels. Proc. Natl. Acad. Sci. USA 2011, 108, 5946–5953. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  21. Xia, X.M.; Fakler, B.; Rivard, A.; Wayman, G.; Johnson-Pais, T.; Keen, J.E.; Ishii, T.; Hirschberg, B.; Bond, C.T.; Lutsenko, S.; et al. Mechanism of calcium gating in small-conductance calcium-activated potassium channels. Nature 1998, 395, 503–507. [Google Scholar] [CrossRef]
  22. Kohajda, Z.; Toth, N.; Szlovak, J.; Loewe, A.; Bitay, G.; Gazdag, P.; Prorok, J.; Jost, N.; Levijoki, J.; Pollesello, P.; et al. Novel Na+/Ca2+ Exchanger Inhibitor ORM-10962 Supports Coupled Function of Funny-Current and Na+/Ca2+ Exchanger in Pacemaking of Rabbit Sinus Node Tissue. Front. Pharmacol. 2019, 10, 1632. [Google Scholar] [CrossRef] [PubMed]
  23. Tsutsui, K.; Monfredi, O.J.; Sirenko-Tagirova, S.G.; Maltseva, L.A.; Bychkov, R.; Kim, M.S.; Ziman, B.D.; Tarasov, K.V.; Tarasova, Y.S.; Zhang, J.; et al. A coupled-clock system drives the automaticity of human sinoatrial nodal pacemaker cells. Sci. Signal. 2018, 11, eaap7608. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Du, X.-J.; Feng, X.; Gao, X.-M.; Tan, T.P.; Kiriazis, H.; Dart, A.M. I(f) channel inhibitor ivabradine lowers heart rate in mice with enhanced sympathoadrenergic activities. Br. J. Pharmacol. 2004, 142, 107–112. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Gal, P.; Klaassen, E.S.; Bergmann, K.R.; Saghari, M.; Burggraaf, J.; Kemme, M.J.B.; Sylvest, C.; Sørensen, U.; Bentzen, B.H.; Grunnet, M.; et al. First Clinical Study with AP30663—A KCa2 Channel Inhibitor in Development for Conversion of Atrial Fibrillation. Clin. Transl. Sci. 2020, 13, 1336–1344. [Google Scholar] [CrossRef]
  26. Vinogradova, T.M.; Bogdanov, K.Y.; Lakatta, E.G. beta-Adrenergic stimulation modulates ryanodine receptor Ca2+ release during diastolic depolarization to accelerate pacemaker activity in rabbit sinoatrial nodal cells. Circ. Res. 2002, 90, 73–79. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Bucchi, A.; Baruscotti, M.; Robinson, R.B.; DiFrancesco, D. Modulation of rate by autonomic agonists in SAN cells involves changes in diastolic depolarization and the pacemaker current. J. Mol. Cell. Cardiol. 2007, 43, 39–48. [Google Scholar] [CrossRef] [PubMed]
  28. Bucchi, A.; Baruscotti, M.; DiFrancesco, D. Current-dependent block of rabbit sino-atrial node I(f) channels by ivabradine. J. Gen. Physiol. 2002, 120, 1–13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Yaniv, Y.; Sirenko, S.; Ziman, B.D.; Spurgeon, H.A.; Maltsev, V.A.; Lakatta, E.G. New evidence for coupled clock regulation of the normal automaticity of sinoatrial nodal pacemaker cells: Bradycardic effects of ivabradine are linked to suppression of intracellular Ca2⁺ cycling. J. Mol. Cell. Cardiol. 2013, 62, 80–89. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  30. Lyashkov, A.E.; Behar, J.; Lakatta, E.G.; Yaniv, Y.; Maltsev, V.A. Positive Feedback Mechanisms among Local Ca Releases, NCX, and I(CaL) Ignite Pacemaker Action Potentials. Biophys. J. 2018, 114, 1176–1189. [Google Scholar] [CrossRef] [PubMed]
  31. Szepesi, J.; Acsai, K.; Sebok, Z.; Prorok, J.; Pollesello, P.; Levijoki, J.; Papp, J.G.; Varro, A.; Toth, A. Comparison of the efficiency of Na+/Ca2+ exchanger or Na+/H+ exchanger inhibition and their combination in reducing coronary reperfusion-induced arrhythmias. J. Physiol. Pharmacol. 2015, 66, 215–226. [Google Scholar] [PubMed]
Figure 1. (A) shows representative immunofluorescent images of rabbit sinus node cells with SK2 and HCN4 immunolabelling. (B) shows the relative expression of SK2 and HCN4. There were no significant changes between the SK2 and HCN4 fluorescence intensity. (C) shows fluorescence colocalization analysis. One data point represents one animal. Four cells were evaluated and averaged from each animal. Data are presented as mean ± SEM, applied statistical probe was unpaired Student’s t-test (p ≤ 0.05).
Figure 1. (A) shows representative immunofluorescent images of rabbit sinus node cells with SK2 and HCN4 immunolabelling. (B) shows the relative expression of SK2 and HCN4. There were no significant changes between the SK2 and HCN4 fluorescence intensity. (C) shows fluorescence colocalization analysis. One data point represents one animal. Four cells were evaluated and averaged from each animal. Data are presented as mean ± SEM, applied statistical probe was unpaired Student’s t-test (p ≤ 0.05).
Pharmaceuticals 15 00313 g001
Figure 2. Characterization of the apamin-sensitive current. (A) illustrates the applied voltage protocol. (B) shows total membrane current under control condition (left curves), after 100 nM apamin application (middle curves), and the apamin sensitive current (right curves). (C) shows the current-voltage diagram of the control and apamin-treated currents and (D) illustrates the current-voltage relationship of the apamin-sensitive current. Statistical analysis was performed by paired t-test (p < 0.05).
Figure 2. Characterization of the apamin-sensitive current. (A) illustrates the applied voltage protocol. (B) shows total membrane current under control condition (left curves), after 100 nM apamin application (middle curves), and the apamin sensitive current (right curves). (C) shows the current-voltage diagram of the control and apamin-treated currents and (D) illustrates the current-voltage relationship of the apamin-sensitive current. Statistical analysis was performed by paired t-test (p < 0.05).
Pharmaceuticals 15 00313 g002
Figure 3. Characterization of the apamin-sensitive current. For further validation, the intracellular solution was heavily buffered with 10 mM BAPTA. Under this condition, the apamin failed to dissect any current from the control recording. (A) shows representative current traces under control condition (blue curve) and in the presence of 100 nM apamin (red curve) at 20 mV voltage pulse. (B) shows the current-voltage diagram where control and apamin resulted in identical curves. Statistical analysis was performed by paired t-test.
Figure 3. Characterization of the apamin-sensitive current. For further validation, the intracellular solution was heavily buffered with 10 mM BAPTA. Under this condition, the apamin failed to dissect any current from the control recording. (A) shows representative current traces under control condition (blue curve) and in the presence of 100 nM apamin (red curve) at 20 mV voltage pulse. (B) shows the current-voltage diagram where control and apamin resulted in identical curves. Statistical analysis was performed by paired t-test.
Pharmaceuticals 15 00313 g003
Figure 4. Measurement of apamin-sensitive current under a representative SAN action potential waveform in the absence and in the presence of 200 nM isoproterenol (ISO). (A) demonstrates the effect of 200 nM isoproterenol on Ca2+ transients. When isoproterenol was omitted, 100 nM apamin (red curve) did not alter the peak of the total current (blue curve, panel (B)). In the presence of 200 nM isoproterenol, 100 nM apamin (red curve) decreased the peak current (green curve, panel (C)). Representative original traces were determined after subtraction of currents. When 200 nM isoproterenol was employed, the apamin-sensitive current (purple curve) was larger than under normal conditions (black curve, panel (D)). Paired and unpaired t-tests (p < 0.05).
Figure 4. Measurement of apamin-sensitive current under a representative SAN action potential waveform in the absence and in the presence of 200 nM isoproterenol (ISO). (A) demonstrates the effect of 200 nM isoproterenol on Ca2+ transients. When isoproterenol was omitted, 100 nM apamin (red curve) did not alter the peak of the total current (blue curve, panel (B)). In the presence of 200 nM isoproterenol, 100 nM apamin (red curve) decreased the peak current (green curve, panel (C)). Representative original traces were determined after subtraction of currents. When 200 nM isoproterenol was employed, the apamin-sensitive current (purple curve) was larger than under normal conditions (black curve, panel (D)). Paired and unpaired t-tests (p < 0.05).
Pharmaceuticals 15 00313 g004
Figure 5. Action potential recordings from isolated SAN cells by perforated patch-clamp technique under normal condition. After control recordings (blue curve), 100 nM apamin was employed (red curve, (A). Bar graphs reported identical cycle lengths (B), short-term cycle length variability (C), APD (D), and slope of diastolic depolarization (E). Statistical analysis was performed by paired t-test.
Figure 5. Action potential recordings from isolated SAN cells by perforated patch-clamp technique under normal condition. After control recordings (blue curve), 100 nM apamin was employed (red curve, (A). Bar graphs reported identical cycle lengths (B), short-term cycle length variability (C), APD (D), and slope of diastolic depolarization (E). Statistical analysis was performed by paired t-test.
Pharmaceuticals 15 00313 g005
Figure 6. Action potential recordings from isolated SAN cells by perforated patch-clamp technique in the presence of 200 nM isoproterenol. The control recordings were measured in the presence of isoproterenol (green curve), then 100 nM apamin was employed (red curve, (A)). Application of apamin increased the cycle length (B) without alteration of the short-term cycle length variability (C), and increased the APD (D) without changing the diastolic depolarization (E). Statistical analysis was performed by paired t-test (p < 0.05).
Figure 6. Action potential recordings from isolated SAN cells by perforated patch-clamp technique in the presence of 200 nM isoproterenol. The control recordings were measured in the presence of isoproterenol (green curve), then 100 nM apamin was employed (red curve, (A)). Application of apamin increased the cycle length (B) without alteration of the short-term cycle length variability (C), and increased the APD (D) without changing the diastolic depolarization (E). Statistical analysis was performed by paired t-test (p < 0.05).
Pharmaceuticals 15 00313 g006
Figure 7. Results of Langendorff-perfused experiments on isolated hearts. (A) demonstrates original ECG traces in control condition (upper panel), in the presence of 200 nM isoproterenol (middle panel), and after apamin application (lower panel). Red vertical dashed lines indicate the change of the cycle lengths. (B) represents the basal condition (i.e., without application of isoproterenol). The ECG R-R interval (left graph) and the R-R variability (right graph) were unaltered after apamin administration. (C) represents apamin application in the presence of 500 nM isoproterenol. 100 nM apamin increased the ECG R-R interval (left graph), however, it did not change the R-R variability (right graph). (D) illustrates the effect of 3 µM ivabradine. Ivabradine markedly increases the R-R interval (left graph) and the R-R interval variability (right graph). (E) shows the comparison of the effects of apamin and ivabradine on the ECG R-R interval after 200 nM isoproterenol. Statistical analysis was performed by paired t-test and repeated measures ANOVA (p < 0.05).
Figure 7. Results of Langendorff-perfused experiments on isolated hearts. (A) demonstrates original ECG traces in control condition (upper panel), in the presence of 200 nM isoproterenol (middle panel), and after apamin application (lower panel). Red vertical dashed lines indicate the change of the cycle lengths. (B) represents the basal condition (i.e., without application of isoproterenol). The ECG R-R interval (left graph) and the R-R variability (right graph) were unaltered after apamin administration. (C) represents apamin application in the presence of 500 nM isoproterenol. 100 nM apamin increased the ECG R-R interval (left graph), however, it did not change the R-R variability (right graph). (D) illustrates the effect of 3 µM ivabradine. Ivabradine markedly increases the R-R interval (left graph) and the R-R interval variability (right graph). (E) shows the comparison of the effects of apamin and ivabradine on the ECG R-R interval after 200 nM isoproterenol. Statistical analysis was performed by paired t-test and repeated measures ANOVA (p < 0.05).
Pharmaceuticals 15 00313 g007
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Bitay, G.; Tóth, N.; Déri, S.; Szlovák, J.; Kohajda, Z.; Varró, A.; Nagy, N. The Inhibition of the Small-Conductance Ca2+-Activated Potassium Channels Decreases the Sinus Node Pacemaking during Beta-Adrenergic Activation. Pharmaceuticals 2022, 15, 313. https://doi.org/10.3390/ph15030313

AMA Style

Bitay G, Tóth N, Déri S, Szlovák J, Kohajda Z, Varró A, Nagy N. The Inhibition of the Small-Conductance Ca2+-Activated Potassium Channels Decreases the Sinus Node Pacemaking during Beta-Adrenergic Activation. Pharmaceuticals. 2022; 15(3):313. https://doi.org/10.3390/ph15030313

Chicago/Turabian Style

Bitay, Gergő, Noémi Tóth, Szilvia Déri, Jozefina Szlovák, Zsófia Kohajda, András Varró, and Norbert Nagy. 2022. "The Inhibition of the Small-Conductance Ca2+-Activated Potassium Channels Decreases the Sinus Node Pacemaking during Beta-Adrenergic Activation" Pharmaceuticals 15, no. 3: 313. https://doi.org/10.3390/ph15030313

APA Style

Bitay, G., Tóth, N., Déri, S., Szlovák, J., Kohajda, Z., Varró, A., & Nagy, N. (2022). The Inhibition of the Small-Conductance Ca2+-Activated Potassium Channels Decreases the Sinus Node Pacemaking during Beta-Adrenergic Activation. Pharmaceuticals, 15(3), 313. https://doi.org/10.3390/ph15030313

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop